Q2 Earnings Estimate for Zymeworks Issued By Leerink Partnrs
Zymeworks Inc. (NYSE:ZYME – Free Report) – Analysts at Leerink Partnrs boosted their Q2 2025 earnings per share estimates for shares of Zymeworks in a research note issued on Monday, April 28th. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings of ($0.56) per share for the quarter, up from their […]
